Deep Track Capital, LP - Significant Ownership

Signature - Title
Nir Messafi - CCO/COO/CFO
Location
Greenwich, CT
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Deep Track Capital, LP.

Significant Ownership of Deep Track Capital, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DVAX Dynavax Technologies Corporation Common Stock, par value $0.001 per share 13.5% $245M 17.8M Deep Track Biotechnology Master Fund, Ltd. Feb 18, 2025
CMPS COMPASS Pathways plc American Depositary Shares, each representing one ordinary share, par value of (pound)0.008 per share 9.99% $34.6M 9.27M Deep Track Capital, LP Jan 10, 2025
RAPT RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share 9.87% $17.6M 14.1M Deep Track Capital, LP Dec 23, 2024
ENGN enGene Holdings Inc. Common Shares 8.94% $24.1M 4.56M Deep Track Capital, LP Dec 31, 2024
TECX Tectonic Therapeutic Inc. Common Stock $0.001 par value per share 7.6% $34.5M 1.4M Deep Track Capital, LP Feb 3, 2025
DNTH Dianthus Therapeutics Inc. Common Stock, $0.001 Par Value 7.34% $50.2M 2.36M Deep Track Capital, LP Mar 17, 2025
MAZE Maze Therapeutics Inc. Common Stock, $0.001 par value per share 6.91% $34.2M 3.02M Deep Track Capital, LP Jan 31, 2025
BCYC Bicycle Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share 6.71% $34.6M 3.33M Deep Track Capital, LP Dec 31, 2024
IMVT Immunovant Inc. Common Stock, $0.0001 par value per share 5.59% $193M 9.5M Deep Track Capital, LP Mar 19, 2025
GERN Geron Corp Common Stock, $0.001 par value 5.5% $56M 35M Deep Track Capital, LP Mar 18, 2025
NRIX Nurix Therapeutics, Inc. Common Stock, par value $0.001 per share 5.44% $54.4M 4.13M Deep Track Capital, LP Feb 7, 2025
ETNB 89bio, Inc. Common stock, par value $0.001 per share 5.41% $46.3M 6.48M Deep Track Capital, LP Dec 19, 2024
PTGX PROTAGONIST THERAPEUTICS, INC. Common Stock, par value $0.00001 5.29% $194M 3.25M Deep Track Capital, LP Apr 3, 2025
GPCR Structure Therapeutics Inc. Ordinary Shares, $0.0001 par value 5.24% $193M 9M Deep Track Capital, LP Jan 6, 2025
IKNA Ikena Oncology, Inc. Common Stock, $0.001 par value 5.21% $4.13M 2.52M Deep Track Capital, LP Feb 7, 2025
SWTX Springworks Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.65% $172M 3.46M Deep Track Capital, LP Dec 31, 2024
OKUR Onkure Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.14% $2.59M 524K Deep Track Capital, LP Dec 31, 2024
FDMT 4D Molecular Therapeutics Inc. Common Stock, par value $0.0001 per share 1.32% $2.52M 610K Deep Track Capital, LP Dec 31, 2024
NKTR Nektar Therapeutics Common Stock, par value $0.0001 1.07% $1.62M 1.98M Deep Track Capital, LP Dec 31, 2024
SYRS Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value 0% $0 0 Deep Track Capital, LP Dec 31, 2024
EDIT Editas Medicine, Inc. Common Stock, $0.0001 par value per share 0% $0 0 Deep Track Capital, LP Dec 31, 2024
PYXS Pyxis Oncology, Inc. Common Stock, par value $0.001 per share 0% $0 0 Deep Track Capital, LP Dec 31, 2024

Schedules 13D/G Reported by Deep Track Capital, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.